MADISON, Wis., April 28, 2014 (GLOBE NEWSWIRE) -- Cellular Dynamics International, Inc. (CDI) (Nasdaq:ICEL) today announced that the company will host a webcast and conference call to discuss its financial results for the first quarter ended March 31, 2014.
|Date:||Tuesday, May 6, 2014|
|Time:||8 a.m. ET|
| Webcast: ||The live webcast can be accessed via the investor relations section of CDI's website at www.cellulardynamics.com and will be archived there following the call for approximately one year.|
|Telephone:||(877) 312-5886 (Domestic)|
|(206) 453-2872 (International)|
|Reference conference ID# 35432190|
About Cellular Dynamics International, Inc.
Cellular Dynamics International, Inc. (CDI) is a leading developer and manufacturer of fully functioning human cells in industrial quantities to precise specifications. CDI's proprietary iCell® Operating System (iCell O/S) includes true human cells in multiple cell types (iCell products), human induced pluripotent stem cells (iPSCs) and custom iPSCs and iCell products (MyCell® Products). CDI's iCell O/S products provide standardized, easy-to-use, cost-effective access to the human cell, the smallest fully functioning operating unit of human biology. Customers use our iCell O/S products, among other purposes, for drug discovery and screening; to test the safety and efficacy of their small molecule and biologic drug candidates; for stem cell banking; and in the research and development of cellular therapeutics. CDI was founded in 2004 by Dr. James Thomson, a pioneer in human pluripotent stem cell research at the University of Wisconsin-Madison. CDI's facilities are located in Madison, Wisconsin, with a second facility in Novato, California. See www.cellulardynamics.com.
CONTACT: MEDIA CONTACTS: Joleen Rau Senior Director, Marketing & Communications Cellular Dynamics International, Inc. (608) 310-5142 firstname.lastname@example.org Investor Relations Gitanjali Jain Ogawa The Trout Group, LLC (646) 378-2949 email@example.comSource:Cellular Dynamics International, Inc.